Evidence map›Paper›PMID 32960427›Full record

ArticleInternational journal of clinical pharmacy2020

Opportunistic screening of cardiovascular disease risk factors in community pharmacies in Nigeria: a cross-sectional study.

Casmir Amadi, Folasade Lawal, Wale Ajiboye, Rosarii Agbim, Amam Mbakwem, Jayne Ajuluchukwu, David A Oke

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of clinical pharmacy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Casmir AmadiDepartment of Medicine, College of Medicine, University of Lagos, Idi-Araba, Lagos, Nigeria. acetalx@yahoo.com.ORCID http://orcid.org/0000-0001-7364-9079
Folasade LawalVictory Drugs Ltd, Festac, Lagos, Nigeria.
Wale AjiboyeSt Michael's Hospital, Toronto, ON, Canada.
Rosarii AgbimSilver Line Pharmacy, Mushin, Lagos, Nigeria.
Amam MbakwemDepartment of Medicine, College of Medicine, University of Lagos, Idi-Araba, Lagos, Nigeria.
Jayne AjuluchukwuDepartment of Medicine, College of Medicine, University of Lagos, Idi-Araba, Lagos, Nigeria.
David A OkeDepartment of Medicine, College of Medicine, University of Lagos, Idi-Araba, Lagos, Nigeria.
University of Lagos · NGSt. Michael's Hospital · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Early identification and treatment of cardiovascular disease (CVD) risk factors through screening are crucial in the primary prevention of CVD and reduction in healthcare-related costs. Use of Non-Physician Healthcare-workers including Community Pharmacists has been advocated as an effective and cost-efficient model of healthcare delivery. In Nigeria the use of community pharmacists for mass screening of CVD risk factors has not been explored. Objective We sought to investigate the possibility of mass CVD risk factor screening in community pharmacies by pharmacists. Setting Lagos, Nigeria. Methods Between October and December 2018 eight hundred and eighty-nine apparently healthy participants were screened for obesity, hypertension, diabetes and hypercholesterolaemia in ten community pharmacies. Diabetes and hypercholesterolaemia were screened for using point-of-care testing modalities. A structured questionnaire was used to obtain the socio-demographic data of the participants. Main outcome measures Prevalence of overweight/obesity, hypertension, diabetes, hypercholesterolaemia, smoking and alcohol intake. Results Mean age of the subjects was 56.8 ± 21.1 years. Majority (57.4%) were females. Prevalence of smoking and alcohol intake were 4.3% and 26.7% respectively. 59.7% and 71.5% of males and females were either overweight (BMI ≥ 25 kg/m

Indexed as

Community Pharmacy ServicesDiagnostic Screening ProgramsLife StyleAdultAgedAlcohol DrinkingCardiovascular DiseasesCross-Sectional StudiesDiabetes MellitusFeasibility StudiesFemaleHeart Disease Risk FactorsHumansHypercholesterolemiaHypertensionMaleCommunity pharmacyCVD risk factorsCVD screeningFeasibility

Identifiers

PMID32960427
OpenAlexW3086999050

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.